Ayurcann Holdings Corp
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPL… Read more
Ayurcann Holdings Corp (AYURF) - Total Assets
Latest total assets as of September 2025: $11.39 Million USD
Based on the latest financial reports, Ayurcann Holdings Corp (AYURF) holds total assets worth $11.39 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ayurcann Holdings Corp - Total Assets Trend (2018–2025)
This chart illustrates how Ayurcann Holdings Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ayurcann Holdings Corp - Asset Composition Analysis
Current Asset Composition (June 2025)
Ayurcann Holdings Corp's total assets of $11.39 Million consist of 80.6% current assets and 19.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.7% |
| Accounts Receivable | $3.96 Million | 31.3% |
| Inventory | $3.72 Million | 29.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.20 Million | 9.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Ayurcann Holdings Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ayurcann Holdings Corp's current assets represent 80.6% of total assets in 2025, a decrease from 100.0% in 2018.
- Cash Position: Cash and equivalents constituted 15.7% of total assets in 2025, down from 99.3% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 31.3% of total assets.
Ayurcann Holdings Corp Competitors by Total Assets
Key competitors of Ayurcann Holdings Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Ayurcann Holdings Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Ayurcann Holdings Corp generates 2.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ayurcann Holdings Corp is currently not profitable relative to its asset base.
Ayurcann Holdings Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.61 | 0.85 | 205.08 |
| Quick Ratio | 0.40 | 0.46 | 205.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-5.88 Million | $ -2.30 Million | $ 1.07 Million |
Ayurcann Holdings Corp - Advanced Valuation Insights
This section examines the relationship between Ayurcann Holdings Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.70 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -14.7% |
| Total Assets | $12.68 Million |
| Market Capitalization | $389.41K USD |
Valuation Analysis
Below Book Valuation: The market values Ayurcann Holdings Corp's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Ayurcann Holdings Corp's assets decreased by 14.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ayurcann Holdings Corp (2018–2025)
The table below shows the annual total assets of Ayurcann Holdings Corp from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $12.68 Million | -14.66% |
| 2024-06-30 | $14.85 Million | +16.68% |
| 2023-06-30 | $12.73 Million | +74.80% |
| 2022-06-30 | $7.28 Million | +9.08% |
| 2021-06-30 | $6.68 Million | +491.79% |
| 2020-06-30 | $1.13 Million | -17.38% |
| 2019-06-30 | $1.37 Million | -15.04% |
| 2018-06-30 | $1.61 Million | -- |